CHU de Toulouse - Hôpital Rangueil
CHU de Toulouse - Hôpital Rangueil
Toulouse, France5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT03767244 | |
| A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab | Unresectable Hepatocellular Carcinoma | Active, not recruiting | Phase 3 | 2026-08-25 | NCT04770896 | |
| PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches | Acute Aortic Syndrome, Aneurysm, Aortic Dissection, Aortic Root Aneurysm, Carotid Artery Injuries, Dissection, Aortic Root, Dissection, Ascending Aorta, Dissection, Blood Vessel, Dissection, Thoracic Aorta, aortic aneurysm, aortic disorder, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebrovascular disorder, injury, nervous system disorder, nervous system injury, thoracic aortic aneurysm, vascular brain injury, vascular disorder | Recruiting | Not stated | 2026-08-20 | NCT04545502 | |
| A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, crescentic glomerulonephritis, immune system disorder, necrotizing vasculitis, rapidly progressive glomerulonephritis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-07-01 | NCT05946564 | |
| Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 4 | 2026-05-26 | NCT07292012 |